Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup | Zendy

Akram Echtay | Zendy; Emile Andari | Zendy; Paola Atallah | Zendy; Roland Moufarrege | Zendy; Rita Nemr | Zendy

Open Access

Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup

Author(s) -

Akram Echtay,

Emile Andari,

Paola Atallah,

Roland Moufarrege,

Rita Nemr

Publication year - 2017

Publication title -

ethnicity and disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 67

eISSN - 1945-0826

pISSN - 1049-510X

DOI - 10.18865/ed.27.1.45

Subject(s) - medicine , glycemic , insulin detemir , type 2 diabetes , adverse effect , insulin , diabetes mellitus , incidence (geometry) , prospective cohort study , gastroenterology , endocrinology , insulin glargine , physics , optics

To evaluate the effectiveness and safety of insulin detemir treatment as add-on therapy in a real-world setting of Lebanese insulin naïve persons, with type 2 diabetes poorly controlled on oral antidiabetic drugs (OADs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research